HomeNewsBusinessCoronavirus pandemic: Uncertainty looms as Trump administration decides to suspend immigration
Trending Topics

Coronavirus pandemic: Uncertainty looms as Trump administration decides to suspend immigration

According to a report by American immigration policy research firm CATO.org, there are about 5,48,641 Indians waiting for their Green Card under skilled worker programme.

April 21, 2020 / 21:58 IST
Story continues below Advertisement

American President Donald Trump’s announcement about suspending immigration has created uncertainty over what it would mean for Indians amid the novel coronavirus outbreak.

Immigration experts point out that unless the executive order is out, it is hard to gauge the impact it will have on the ecosystem.

Story continues below Advertisement

Shivendra Singh, Vice President and Head, Global Trade Development, NASSCOM, said the industry body is trying to get details on the executive order of President Trump and currently no details are available. “Once we get the details, we will respond to the same,” Singh added.

Netra Chavan, who runs one of the largest Facebook groups for H1-B and H4 visa holders, echoed a similar sentiment. However, she added that people with valid visa status in the US should not be worried.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show